OFIX vs. ATRC, IART, SRDX, ANGO, ARAY, RMTI, RSLS, ABT, ISRG, and BSX
Should you be buying Orthofix Medical stock or one of its competitors? The main competitors of Orthofix Medical include AtriCure (ATRC), Integra LifeSciences (IART), Surmodics (SRDX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), and Boston Scientific (BSX). These companies are all part of the "health care equipment" industry.
Orthofix Medical vs.
AtriCure (NASDAQ:ATRC) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, community ranking, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.
In the previous week, Orthofix Medical had 5 more articles in the media than AtriCure. MarketBeat recorded 10 mentions for Orthofix Medical and 5 mentions for AtriCure. AtriCure's average media sentiment score of 1.54 beat Orthofix Medical's score of 0.74 indicating that AtriCure is being referred to more favorably in the media.
AtriCure presently has a consensus price target of $50.67, indicating a potential upside of 51.74%. Orthofix Medical has a consensus price target of $23.33, indicating a potential upside of 101.67%. Given Orthofix Medical's higher possible upside, analysts plainly believe Orthofix Medical is more favorable than AtriCure.
AtriCure has a beta of 1.59, indicating that its stock price is 59% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500.
AtriCure has a net margin of -9.61% compared to Orthofix Medical's net margin of -15.18%. AtriCure's return on equity of -6.80% beat Orthofix Medical's return on equity.
AtriCure has higher earnings, but lower revenue than Orthofix Medical. AtriCure is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.
99.1% of AtriCure shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 3.5% of AtriCure shares are owned by insiders. Comparatively, 1.3% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
AtriCure received 160 more outperform votes than Orthofix Medical when rated by MarketBeat users. Likewise, 69.72% of users gave AtriCure an outperform vote while only 61.93% of users gave Orthofix Medical an outperform vote.
Summary
AtriCure beats Orthofix Medical on 14 of the 18 factors compared between the two stocks.
Get Orthofix Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Orthofix Medical Competitors List
Related Companies and Tools
This page (NASDAQ:OFIX) was last updated on 6/11/2025 by MarketBeat.com Staff
Buy OFIX Stock Free OFIX Stock Alerts